These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17220701)

  • 1. Evaluation of a combined screening programme for breast, cervical and colorectal cancers in France.
    Billette de Villemeur A; Exbrayat C; Garnier A; Ancelle-Park R; Ferley JP; Jestin C
    Eur J Cancer Prev; 2007 Feb; 16(1):26-35. PubMed ID: 17220701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
    Yeoh KG; Chew L; Wang SC
    J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast, cervical and colo-rectal simultaneous mass screening program for women 50 to 69 years old in Isere].
    Garnier A; Exbrayat C; Marron J; Seigneurin D; Winckel P; Bolla M
    Sante Publique; 2000 May; 12 Spec No():59-69. PubMed ID: 10989629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Simultaneous screening of cancers of the breast, cervix, colon and rectum. The Isère experience].
    Exbrayat C; Garnier A; Bolla M; Winckel P; Salicru B; Marron J; Faure H; Menegoz F; Billette de Villemeur A
    Bull Cancer; 1996 Aug; 83(8):641-8. PubMed ID: 8869044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Campaign for cervical cancer screening with vaginal smears in women aged 50-69 years in Isère (France). Results of the first round (January 1991-June 1993)].
    Garnier A; Exbrayat C; Bolla M; Marron J; Winckel P; Billette de Villemeur A
    Bull Cancer; 1997 Aug; 84(8):791-5. PubMed ID: 9339183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast and cervical cancer screening activities among family physicians in Nigeria.
    Ajayi IO; Adewole IF
    Afr J Med Med Sci; 2002 Dec; 31(4):305-9. PubMed ID: 15027768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
    Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
    J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A; Ozkilinc G; Guler A; Oztop I
    Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the follow-up of women aged 50-74 years after cervical cytological Ascus abnormalities in cancer screening: adherence to clinical practice guidelines in Isere, France; 1991-2000].
    Billette-de-Villemeur A; Poncet F; Garnier A; Marron J; Le Marc'hadour F; Morens A; Rouault-Plantaz V; Ney M; Exbrayat C
    Gynecol Obstet Fertil; 2009 Oct; 37(10):787-95. PubMed ID: 19782628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
    Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
    Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Education program for general practitioners on breast and cervical cancer screening: a randomized trial. PRE.SA.GF Collaborative Group.
    Boissel JP; Collet JP; Alborini A; Cordel JC; Filsnoel J; Gillet J; Nemoz C; Brémond A; Bernhard G; Bourdin JF
    Rev Epidemiol Sante Publique; 1995 Dec; 43(6):541-7. PubMed ID: 8552852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.
    Malila N; Anttila A; Hakama M
    J Med Screen; 2005; 12(1):28-32. PubMed ID: 15814016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in abnormal cancer screening results in the United States of America.
    Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
    J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
    van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.